Bioqual BIOQ Stock
Bioqual Price Chart
Bioqual BIOQ Financial and Trading Overview
| Bioqual stock price | 38.51 USD |
| Previous Close | 76 USD |
| Open | 82 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 76 - 76 USD |
| 52 Week Range | 57 - 104 USD |
| Volume | 100 USD |
| Avg. Volume | 28 USD |
| Market Cap | 68.1M USD |
| Beta (5Y Monthly) | -0.283098 |
| PE Ratio (TTM) | 12.367779 |
| EPS (TTM) | 2.43 USD |
| Forward Dividend & Yield | 1 (1.32%) |
| Ex-Dividend Date | October 5, 2022 |
| 1y Target Est | N/A |
BIOQ Valuation Measures
| Enterprise Value | 83.11M USD |
| Trailing P/E | 12.367779 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0486141 |
| Price/Book (mrq) | 1.7740843 |
| Enterprise Value/Revenue | 1.28 |
| Enterprise Value/EBITDA | 13.781 |
Trading Information
Bioqual Stock Price History
| Beta (5Y Monthly) | -0.283098 |
| 52-Week Change | 33.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 104 USD |
| 52 Week Low | 57 USD |
| 50-Day Moving Average | 77.44 USD |
| 200-Day Moving Average | 78.4 USD |
BIOQ Share Statistics
| Avg. Volume (3 month) | 28 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 896K |
| Float | 891.85K |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1 |
| Trailing Annual Dividend Yield | 1.31% |
| 5 Year Average Dividend Yield | 147.00% |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2022 |
| Most Recent Quarter (mrq) | February 28, 2023 |
| Next Fiscal Year End | May 31, 2023 |
Profitability
| Profit Margin | 5.27% |
| Operating Margin (ttm) | 6.05% |
| Gross Margin | 23.22% |
| EBITDA Margin | 9.28% |
Management Effectiveness
| Return on Assets (ttm) | 3.97% |
| Return on Equity (ttm) | 9.24% |
Income Statement
| Revenue (ttm) | 64.94M USD |
| Revenue Per Share (ttm) | 72.61 USD |
| Quarterly Revenue Growth (yoy) | -17.69% |
| Gross Profit (ttm) | 16.95M USD |
| EBITDA | 6.03M USD |
| Net Income Avi to Common (ttm) | 3.43M USD |
| Diluted EPS (ttm) | 6.145 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.36M USD |
| Total Cash Per Share (mrq) | 4.88 USD |
| Total Debt (mrq) | 19.5M USD |
| Total Debt/Equity (mrq) | 50.89 USD |
| Current Ratio (mrq) | 4.308 |
| Book Value Per Share (mrq) | 42.839 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.88M USD |
| Levered Free Cash Flow (ttm) | 7.99M USD |
Profile of Bioqual
| Country | United States |
| State | MD |
| City | Rockville |
| Address | 9600 Medical Center Drive |
| ZIP | 20850-3336 |
| Phone | 240 404 7654 |
| Website | https://www.bioqual.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Q&A For Bioqual Stock
What is a current BIOQ stock price?
Bioqual BIOQ stock price today per share is 38.51 USD.
How to purchase Bioqual stock?
You can buy BIOQ shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bioqual?
The stock symbol or ticker of Bioqual is BIOQ.
Which industry does the Bioqual company belong to?
The Bioqual industry is Diagnostics & Research.
How many shares does Bioqual have in circulation?
The max supply of Bioqual shares is 894.42K.
What is Bioqual Price to Earnings Ratio (PE Ratio)?
Bioqual PE Ratio is 15.84773500 now.
What was Bioqual earnings per share over the trailing 12 months (TTM)?
Bioqual EPS is 2.43 USD over the trailing 12 months.
Which sector does the Bioqual company belong to?
The Bioqual sector is Healthcare.